Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-09-22

Clinical Trial Update: Clinical Trial to Treat Stage IV Cancer Patients [Phase 1]

View source ↗

Summary

Moonshot Antibodies announced a Phase 1 trial enrolling patients with Stage IV soft tissue sarcoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Moonshot Antibodies | Conditions: Soft Tissue Cancer | Phase 1 | Status: ENROLLING_BY_INVITATION